Navigation Links
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010
Date:9/27/2010

{ var s = ''; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { //s += key + ":" + first_result[key].toString() + "
"; if(key == "shortUrl") { shortURL = first_result[key].toString(); break; } } PostTwitter(); } function readCookie(name){ var cookieValue = ""; var search = name + "="; if(document.cookie.length > 0){ offset = document.cookie.indexOf(search); if (offset != -1){ offset += search.length; end = document.cookie.indexOf(";", offset); if (end == -1) end = document.cookie.length; cookieValue = unescape(document.cookie.substring(offset, end)) } } return cookieValue; } window.onload=function(){ OnNewsreleaseLoad(); var userid = readCookie('DMUserTrack'); var csid = 103849863; var newstogramURL = 'http://www.prnewswire.com/templates/PRN_MultiVu_URL_Reader?userid='+userid+'&csid='+csid; //var newstogramURL ='http://www.prnewswire.com/templates/prnwConfig.xml'; var delay = function() { sendToFlash('StartPlay',newstogramURL); }; setTimeout(delay,100,"JavaScript"); //setTimeout("sendToFlash('StartPlay', 'http://www.prnewswire.com/templates/prnwConfig.xml')",100); }; function ShortenURL() { //Bit.ly function call to shorten url BitlyClient.call('shorten', {'longUrl': formatURL()}, 'BitlyCB.alertResponse'); }

Advanced Search<
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
2. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
3. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
4. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
5. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
6. Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
7. Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
8. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences
10. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
11. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
(Date:5/20/2015)... This year has been one of the harshest ... Pearl’s Premium Ultra Low Maintenance Lawn Seed comes to ... coming out of record bad weather. Offering new ... concerns related to water, health, and climate change, Pearl's ... the standard, water-wasting, chemical-treated standard lawn. Many homeowners ...
(Date:5/20/2015)... Agricultural firm H.J. Baker & Bro., ... of Tiger-Sul. Since the purchase of Tiger Industries ... May 2005, H.J. Baker has leveraged the innovation of ... comprehensive portfolio of product offerings and solutions expertise. The ... the innovation of Tiger-Sul, transforming the company into a ...
(Date:5/20/2015)... May 19, 2015 Research and Markets ... of the "Bone Morphogenetic Proteins Market (Types ... Reconstructive and Oral - Maxillofacial) - Global Industry ... - 2022" report to their offering. ... studied based on the types of recombinant BMPs, ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 2Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 3Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2
... therapy market to grow rapidly ... over next decade, WALTHAM, Mass., Sept. ... cell therapy market in,its US Markets for Stem Cell Therapies 2007 report. The ... it will,grow rapidly as products are approved in the US. Today, only two ...
... UNION CITY, Calif., Sept. 13 Abaxis, Inc.,(Nasdaq: ... point-of-care,blood analysis systems, announced today that Clint Severson, ... Company, LLC Sixth Annual San,Francisco Institutional Investor Forum ... Pacific Time at The Ritz-Carlton Hotel in San ...
... Corporation (Nasdaq: MEND ) today announced that its ... over the,Internet on Thursday, September 20, 2007 at 12:00 ... the meeting via the live Internet,broadcast will not have ... Micrus Endovascular Fiscal 2007 Annual Meeting of Stockholders, ...
Cached Biology Technology:Stem Cell Therapy to Skyrocket by 2017 2Micrus Endovascular to Webcast Fiscal 2007 Annual Meeting of Stockholders 2
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/13/2015)... 13, 2015  higi, a leading cloud-based consumer engagement ... fully engage with their communities around health and wellness, ... and secure API.  ... accessible, affordable, and convenient vehicle to receive validated health ... The API will allow higi,s trusted partners, ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
... senior scientist at the Marshall Institute for Interdisciplinary Research (MIIR), ... of Health to lead a project to develop a technique ... The project will combine the expertise of two research groups ... growth and development, and his team at MIIR will be ...
... This news release is available in German ... reported in the current issue of the " Journal of Clinical ... repair mechanisms begin to fail with increasing age. As a result, ... diseases, including Alzheimer,s disease, diabetes, cardiovascular disorders and cancer, increases. "Current ...
... in the journal Nature reveals for the first ... can change sea surface temperatures on seasonal and longer timescales. ... ocean that takes up heat from the atmosphere, these changes ... a new measurement of mixing, Jim Moum and Jonathan Nash ...
Cached Biology News:MIIR scientist awarded $293,000 NIH grant 2Rapamycin: Limited anti-aging effects 2Rapamycin: Limited anti-aging effects 3Study explains Pacific equatorial cold water region 2Study explains Pacific equatorial cold water region 3
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
Biology Products: